Literature DB >> 12832972

Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?

Osamu Ishikawa1, Hiroshi Wada, Hiroaki Ohigashi, Yuichiro Doki, Shigekazu Yokoyama, Shingo Noura, Terumasa Yamada, Yo Sasaki, Shingi Imaoka, Tsutomu Kasugai, Takashi Matsunaga, Akemi Takenaka, Akihiko Nakaizumi.   

Abstract

OBJECTIVE: To evaluate the postoperative cytology of drained fluid from the pancreatic bed as a predictive indicator of local recurrence after curative (R0) resection of pancreatic cancer. SUMMARY BACKGROUND DATA: The pancreatic bed offers a common site of cancer recurrence (local recurrence), even after curative (R0) resection is performed for pancreatic cancer. If local recurrence is thereby predicted precisely, soon after surgery, we have a chance to treat it by adding radiation or some other locoregional therapy before it can grow or spread beyond the pancreatic bed. However, there have been no previous reports of cytology performed on the drained fluid after pancreatectomy.
METHODS: This study includes 94 patients who had shown negative results in the peritoneal washing cytology before resection and subsequently received pancreatectomies for pancreatic tumors. They consisted of 12 benign tumors, 17 noninvasive or minimally invasive carcinomas and 65 invasive ductal carcinomas (R0 = 58; R1/2 = 7). Postoperatively, the drained fluid from the pancreatic bed was collected for 24 hours and used for cytologic examination. The cytologic results were examined in association with the histopathology of the resected tumor, patient's survival, and mode of cancer recurrence, including local recurrence.
RESULTS: Patients with benign tumors or noninvasive/minimally invasive carcinomas had negative result in cytology, and none of them have died of local recurrence (limited to the pancreatic bed) to date. However, patients with invasive ductal carcinoma revealed higher cytology-positive rates: 28% (16/58) in curative (R0) resection; and 71% (5/7) in noncurative (R1/2) resection. Among 58 patients with R0 resection, the 3-year survival rate was 14% in 16 cytology-positive patients and 55% in 42 cytology-negative patients (P < 0.05). The 3-year cumulative rate of local recurrence was 85% and 23%, respectively (P < 0.05). Compared with other histopathologic parameters obtained from the resected specimens, the drain cytology was more specific in predicting the subsequent development of local recurrence.
CONCLUSIONS: Drain-cytology was a quick examination that enabled us to specifically indicate both minute residual cancer and subsequent development of local recurrence even after R0 resection of pancreatic cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12832972      PMCID: PMC1422659          DOI: 10.1097/01.SLA.0000074982.51763.d6

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  16 in total

1.  Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Cancer       Date:  1987-06-15       Impact factor: 6.860

2.  Does pleural lavage cytology before thoracic closure predict both patient's prognosis and site of cancer recurrence after resection of esophageal cancer?

Authors:  Y Doki; T Kabuto; O Ishikawa; H Ohigashi; Y Sasaki; T Yamada; M Hiratsuka; I Miyashiro; M Kameyama; K Murata; S Imaoka; T Yasuda; A Nakaizumi; A Takenaka
Journal:  Surgery       Date:  2001-11       Impact factor: 3.982

3.  Peritoneal washing cytology combined with immunocytochemical staining and detecting mutant K-ras in pancreatic cancer: comparison of the sensitivity and availability of various methods.

Authors:  S Nomoto; A Nakao; Y Kasai; S Inoue; A Harada; T Nonami; H Takagi
Journal:  Pancreas       Date:  1997-03       Impact factor: 3.327

4.  Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients.

Authors:  A L Warshaw; C C Compton; K Lewandrowski; G Cardenosa; P R Mueller
Journal:  Ann Surg       Date:  1990-10       Impact factor: 12.969

5.  K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head: distribution pattern and related factors.

Authors:  H Ohigashi; O Ishikawa; Y Sasaki; T Yamada; H Furukawa; S Imaoka; T Kasugai; S Ishiguro; K Ueda; Y Miyoshi; Y Nakamura
Journal:  Arch Surg       Date:  2000-12

6.  Surgical techniques of cytology-guided pancreatectomy for occult neoplasm of the pancreas.

Authors:  O Ishikawa; H Ohigashi; S Imaoka; A Takenaka; H Uehara; A Nakaizumi
Journal:  Hepatogastroenterology       Date:  1995 Sep-Oct

7.  Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head.

Authors:  O Ishikawa; H Ohhigashi; Y Sasaki; T Kabuto; I Fukuda; H Furukawa; S Imaoka; T Iwanaga
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

8.  Patterns of failure after curative resection of pancreatic carcinoma.

Authors:  J F Griffin; S R Smalley; W Jewell; J C Paradelo; R D Reymond; R E Hassanein; R G Evans
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

9.  Intraoperative cytodiagnosis for detecting a minute invasion of the portal vein during pancreatoduodenectomy for adenocarcinoma of the pancreatic head.

Authors:  O Ishikawa; H Ohigashi; Y Sasaki; H Nakano; H Furukawa; S Imaoka; A Takenaka; T Kasugai; S Ishiguro
Journal:  Am J Surg       Date:  1998-06       Impact factor: 2.565

10.  Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head.

Authors:  S D Leach; J A Rose; A M Lowy; J E Lee; C Charnsangavej; J L Abbruzzese; R L Katz; D B Evans
Journal:  Surgery       Date:  1995-09       Impact factor: 3.982

View more
  12 in total

Review 1.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

2.  Complications of endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB) for pancreatic lesions.

Authors:  Kenji Yamao
Journal:  J Gastroenterol       Date:  2005-09       Impact factor: 7.527

3.  Detection of disseminated tumor cells in aspirative drains after neck dissection.

Authors:  R Mastronicola; C Berteau; Q Tu; S Cortese; J Guillet; B Phulpin; P Gangloff; L Bezdetnaya; J-L Merlin; G Faure; G Dolivet
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-30       Impact factor: 2.503

4.  Impact of reconstruction methods on outcome of pancreatoduodenectomy in pancreatic cancer patients.

Authors:  Ryuichiro Doi; Koji Fujimoto; Hiroyuki Kobayashi; Masayuki Imamura
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

Review 5.  Incidence and prognostic significance of positive peritoneal lavage in colorectal cancer.

Authors:  Takeshi Nishikawa; Eiji Sunami; Toshiaki Tanaka; Junichiro Tanaka; Tomomitsu Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hiroaki Nozawa; Soichiro Ishihara; Toshiaki Watanabe
Journal:  Surg Today       Date:  2014-11-07       Impact factor: 2.549

6.  Resection of a cancer developing in the remnant pancreas after a pancreaticoduodenectomy for pancreas head cancer.

Authors:  Susumu Takamatsu; Daisuke Ban; Takumi Irie; Norio Noguchi; Atsushi Kudoh; Noriaki Nakamura; Tohru Kawamura; Tohru Igari; Kenichi Teramoto; Shigeki Arii
Journal:  J Gastrointest Surg       Date:  2005-02       Impact factor: 3.452

7.  Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.

Authors:  Kyohei Ariake; Fuyuhiko Motoi; Hideo Ohtsuka; Koji Fukase; Kunihiro Masuda; Masamichi Mizuma; Hiroki Hayashi; Kei Nakagawa; Takanori Morikawa; Shimpei Maeda; Tatsuyuki Takadate; Takeshi Naitoh; Shinichi Egawa; Michiaki Unno
Journal:  Surg Today       Date:  2017-04-22       Impact factor: 2.549

8.  Pancreatic cancer: surgery alone is not sufficient.

Authors:  L W Traverso
Journal:  Surg Endosc       Date:  2006-03-23       Impact factor: 4.584

9.  Cancer cells with p53 deletion detected by fluorescent in situ hybridization in peritoneal drainage fluid is correlated with early peritoneal seeding in resectable pancreatic cancer.

Authors:  Mee Joo Kang; Sung-Sik Han; Jin-Young Jang; Jae Woo Park; Wooil Kwon; Ye Rim Chang; Sun-Whe Kim
Journal:  J Korean Surg Soc       Date:  2013-03-26

10.  Original Scientific Reports: Clinicopathological Findings of Remnant Pancreatic Cancers in Survivors Following Curative Resections of Pancreatic Cancers.

Authors:  Shuji Suzuki; Toru Furukawa; Nana Oshima; Wataru Izumo; Kyoko Shimizu; Masakazu Yamamoto
Journal:  World J Surg       Date:  2016-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.